Diabetes, Heart and Cardiovascular Diseases News Chronicle.  Diabetes, Cardiovascular and Heart Diseases
 Article 192
    Published on May 20, 2017


Eating Avocados Reduces Heart Disease and Body Weight

A study funded by the Hass Avocado Board by the researchers at Louisiana State University, the United States show a reduction in body weight and reduction in risk of heart diseases with the consumption of avocados. Avocado fruit weighs between 220 grams to 1.4 kg (or between 8 ounces to 3 pounds). The researchers conducted studies among 30,000 individuals with the consumption of avocados. Their study results show following health benefits with the consumption avocado when compared with non-consumers of avocado.


Health factor Benefit
Body weight 7.5 lbs less
Waist diameter 1.2 inches less
Metabolic syndrome 32 percent less
Insulin levels 21 percent less
Homocysteine levels 9 percent less

Researchers say avocados contains essential nutrients such as minerals (magnesium, folate, potassium and copper), vitamin E and vitamin C, fiber and healthy fats. Consumption of avocados results in better health parameters for an individual and should be part of healthy lifestyle. Avocados contain oleic acid, which is a monounsaturated fat. Olive oil also contains the same fat. Most of the calories (77 percent) come from oleic acid in avocados. Earlier studies show avocados are associated with lower risk of heart diseases, inflammation, anti-aging and cancer. Author of the study was Dr. Carol O'Neil, from Louisiana State University, the United States and the study findings were published in the journal Internal Medicine Review.




       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK to your social media is (copy and paste the code below) :

Articles similar to this topic


1. A Study Says Avocados Increases Heart Disease Risks
2. Risks With Body Weight
3. About Meizus H1 Wearable Device
4. Wearable Devices Market
5. About Esysta device

 

 

Daily Dose Of Cinnamon Reduce Heart Attack Risk Associated With A High-Fat Diet

A study done by researchers shows risk reduction to cardiovascular events associated with a high-fat diet with the consumption of cinnamon. Animal studies with cinnamon show slowdown in the fat storing process of the body as cinnamon activate anti-inflammatory and antioxidant systems of the body. The researchers conducted an experiment with rat models for 12 weeks duration. Researchers found following healthy health factors in those rat models fed with a high-fat diet along with cinnamon supplements when compared with rat models fed with a high-fat diet but without cinnamon supplements.


  • Weight is less
  • Less belly fat and blood fat
  • Healthy levels of blood sugar or glucose levels
  • Healthy levels of insulin

Earlier studies show cinnamon association with the improvement in hippocampus part of the brain. Hippocampus part in the brain is associated with memory function of an individual. The study findings were presented in the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology.




       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK to your social media is (copy and paste the code below) :

Articles similar to this topic


1. Health Benefits With Cinnamon
2. Risks With A High-Fat Meal
3. Discovery Of TST - TST Protects From High-Fat
4. Wearable Contact Lenses To Measure Blood Sugar Levels
5. Wearable Technology For Elder Care

 

 

Trials Of Oral Anti-Diabetic Imeglimin Drug From Poxel

Imeglimin is an oral anti-diabetic and an experimental drug being developed by Poxel. This drug is intended to restore normal insulin secretion, improve glucose uptake of muscles and prevents hepatic gluconeogenesis (GNG). A phase 2B trial of imeglimin has met its primary endpoint and the company is going to conduct phase 3 trials by the end of 2017 after meeting Japanese regulators. Japanese investigators have conducted trials with 299 diabetes patients. Trials results show imeglimin is better than placebo in reducing glycated hemoglobin A1c, which shows 3-month average glucose levels of an individual.




       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK to your social media is (copy and paste the code below) :

Articles similar to this topic


1. Oral Health Helps Managing Diabetes
2. Oral Insulin Based On Cholestosome Technology
3. Wearable Device To Alleviate Stress and Anxiety
4. Chameleon Wearable Fitness Tracker From Adidas
5. Wearable Belt Type Medical Device To Treat Diabetes In Obese Individuals

 

Gluconeogenesis : Gluconeogenesis (GNG) is a metabolic pathway that results in the production of glucose.

 

 

Site maps

Site map 1   Site map 2   Site map 3   Site map 4


The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.